Contract facts
UnrestrictedNo full NAICS 325412 intel page yet. Browse NAICS intelligence
503A AND 503B ADMIXTURE PHARMACY is a federal Unrestricted award for Defense Health Agency held by Central Admixture Pharmacy Services, Inc. Estimated value $250K ($250K obligated). Current period of performance ends Feb 28, 2023. Last award drew 1 bidder. Place of performance: IRVINE CA.
Recompete timing
PublicCurrent PoP ended Feb 28, 2023 (1310 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on HT001423F0050? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordCentral Admixture Pharmacy Services, Inc — $5.4M obligated across 70 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001423F0050?
HT001423F0050 (503a and 503b admixture pharmacy) is a Defense Health Agency award with a potential value of $250K, currently held by Central Admixture Pharmacy Services, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT0014-23-F-0050?
HT0014-23-F-0050 is the dashed form of PIID HT001423F0050 (503a and 503b admixture pharmacy), held by Central Admixture Pharmacy Services, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT001423F0050?
Defense Health Agency awarded HT001423F0050 to Central Admixture Pharmacy Services, Inc (potential $250K).
Who is the incumbent on HT001423F0050?
Central Admixture Pharmacy Services, Inc is the incumbent with $5.4M across 70 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2023.
When does Central Admixture Pharmacy Services, Inc’s HT001423F0050 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT001423F0050? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.